Prostate Cancer Treatment Advancement Using External Beam Radiotherapy by Tandon, R. et al.
12 World Journal of Oncology Research, 2015, 2, 12-13  
 
© 2015 Cosmos Scholars Publishing House 
Editorial 
Prostate Cancer Treatment Advancement Using External Beam 
Radiotherapy 
R. Tandon*, P. Malakar and B. Rathod 
Madhav Nagar, Near Tiger circle, Manipal, Karnataka 576104, India 
Keywords: Prostate Cancer, Radiation Therapy. 
Prostate cancer is considered as one of the most 
frequently diagnosed cancer among men in the USA 
and world. [1] Prostate cancer typically occurs in men 
after 50 years old, and the frequent and affordable PSA 
testing among men has led to increased number of 
prostate cancer diagnosis across the globe. Surgery is 
one of the options to manage the prostate cancer. 
However, some patients prefer other treatment options 
such as radiotherapy. In the last 10 years, there has 
been an increasing use of radiotherapy for cancer 
treatment. The latest advancement in technology has 
also further improved the efficiency of radiotherapy 
treatment.  
In the late 1990s,  3-dimensional conformal radio- 
therapy (3DCRT) was the most common type of 
modality. In early 2000s, intensity modulated radiation 
therapy (IMRT) became popular due to superior dose 
distributions in the case of irregular shaped target 
volume when compared to 3DCRT. In 2007, volumetric 
modulated arc therapy (VMAT) has come into the 
market, and the VMAT is now considered as the most 
advanced form of the radiotherapy technique in the 
photon modality. The main difference between the 
IMRT and VMAT is that VMAT delivers the dose while 
the machine is rotating around the patient, whereas the 
IMRT delivers the dose in the form of static beams. [2, 
3] Both the IMRT and VMAT are now commonly used 
to treat the prostate cancer, and the comparison 
between IMRT and VMAT for the prostate cancer 
treatment has become topic of studies among may 
investigators in the last few years. [4-8] 
The literature review shows that both the IMRT and 
VMAT are capable of delivering excellent dose 
distributions to the prostate cancer volume while 
minimizing dose to the critical structures such as 
rectum and bladder. [4-8] It is a known fact that the 
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patient anatomy and tumor location may not be same 
among different patients. Hence, the treatment 
planning results of one case may not be exactly 
applicable to another case. Since there are various 
influencing parameters in the treatment planning of the 
prostate cancer, it has been noted that the results of 
one study can be contradictory to the other one. For 
example, treatment planning system itself varies from 
one vendor to another, and this can lead to different 
planning results. The type of dose calculation engine to 
calculate the prostate plans can give different IMRT 
and VMAT results. [9] Dosimetric plans also vary 
depending on the experience of the treatment planning 
personnel. The experience and skillful planners are 
able to generate superior treatment plans of the 
prostate cancer. Kopp et al [4] found out that VMAT 
can produce better results than IMRT for prostate 
cancer patients by achieving lower dose to the critical 
structures while having the same target coverage. 
Even with the VMAT, one can have an option of using 
one arc, two arcs, three arcs, etc. Rana et al [6] and 
other researchers have demonstrated that single arc 
technique can produce different results when 
compared to double arc technique. Again, the partial-
single arc technique using avoidance sectors could 
produce better results by reducing rectal and bladder 
dose as demonstrated by Rana et al [6]. Reduction of 
rectal and bladder dose can reduce the normal tissue 
toxicities, thus improving the quality of life of prostate 
cancer patients.  
Stereotactic body radiation therapy (SBRT) is also 
being used to treat the prostate cancer. The SBRT is 
generally delivered using high dose in 3-5 fractions. 
Researchers have reported encouraging clinical results 
such as rectal and bladder toxicities, erectile function, 
and early PSA response due to use of SBRT for 
prostate cancer. [10] The successful delivery of these 
external beam radiotherapy modalities is now possible 
due to the advancement in the image guided 
radiotherapy (IGRT). The image guidance is essential 
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in order to deliver the radiation beam to the geometric 
tumor volume. An example is a cone-beam computed 
tomography (CBCT), which can be used to verify the 
patient setup and tumor localization prior to IMRT, 
VMAT, and SBRT beam delivery. 
Proton therapy is another advanced radiotherapy 
technique and the use of protons to treat prostate 
cancer is very promising. Several investigations have 
evaluated the proton and photon therapy for prostate 
cancer, and the results show the superiority of proton 
therapy over the photon therapy [11-14]. The idea of 
using proton therapy for prostate cancer treatment is 
appealing since proton therapy allows deposition most 
of the radiation dose in the tumor volume when 
compared to the photon therapy. Hence, proton 
therapy can improve the prostate cancer treatment by 
reducing dose to the rectum and bladder, which are 
two major critical structures next to the prostate 
volume. 
Prostate cancer treatment using radiotherapy, 
however, is not completely free from the side effects. 
Common side effects experienced by prostate cancer 
patients undergone radiotherapy include rectal 
bleeding, urinary complications, hip fractures, etc. 
Recent publication by Nguyen et al [15] showed that 
advanced treatment techniques can produce better 
biochemical, clinical, and survival outcomes. Shiraishi 
et al [16] reported reduced acute and late toxicities for 
prostate cancer patients treated using VMAT than 
using conventional radiotherapy techniques. Future 
clinical trials need to include prostate cancer patients 
treated using VMAT technique to further analyze the 
clinical results.  
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